| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Mortality | 7 | 2021 | 7132 | 0.94 | Why? |
| Hematinics | 2 | 2017 | 48 | 0.85 | Why? |
| Cesarean Section, Repeat | 1 | 2018 | 8 | 0.78 | Why? |
| Vaginal Birth after Cesarean | 1 | 2018 | 16 | 0.76 | Why? |
| Health Status | 4 | 2021 | 3259 | 0.76 | Why? |
| Parasympatholytics | 1 | 2017 | 7 | 0.72 | Why? |
| Cost Control | 1 | 2018 | 35 | 0.72 | Why? |
| Hospitals, Maternity | 1 | 2018 | 154 | 0.69 | Why? |
| Biosimilar Pharmaceuticals | 2 | 2017 | 205 | 0.67 | Why? |
| Antiemetics | 1 | 2017 | 75 | 0.65 | Why? |
| Medical Marijuana | 1 | 2017 | 55 | 0.64 | Why? |
| Neuralgia | 1 | 2017 | 99 | 0.62 | Why? |
| Hypothyroidism | 1 | 2018 | 239 | 0.62 | Why? |
| Italy | 34 | 2021 | 38444 | 0.56 | Why? |
| Drug Substitution | 1 | 2018 | 385 | 0.56 | Why? |
| Narcotics | 1 | 2014 | 67 | 0.54 | Why? |
| National Health Programs | 2 | 2018 | 807 | 0.54 | Why? |
| Maintenance Chemotherapy | 1 | 2014 | 133 | 0.53 | Why? |
| Hospital Records | 1 | 2013 | 55 | 0.52 | Why? |
| Research Support as Topic | 1 | 2018 | 327 | 0.52 | Why? |
| Evidence-Based Medicine | 6 | 2018 | 3228 | 0.52 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2017 | 365 | 0.50 | Why? |
| Anemia | 2 | 2017 | 789 | 0.50 | Why? |
| Analgesics | 1 | 2017 | 451 | 0.50 | Why? |
| Program Evaluation | 2 | 2018 | 1929 | 0.49 | Why? |
| Incidental Findings | 1 | 2017 | 487 | 0.48 | Why? |
| Research Design | 2 | 2018 | 5830 | 0.45 | Why? |
| Phytotherapy | 1 | 2017 | 743 | 0.41 | Why? |
| Bipolar Disorder | 1 | 2018 | 744 | 0.40 | Why? |
| Antipsychotic Agents | 1 | 2018 | 887 | 0.39 | Why? |
| Quality of Health Care | 2 | 2018 | 1948 | 0.38 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.37 | Why? |
| Renal Insufficiency, Chronic | 3 | 2017 | 2654 | 0.36 | Why? |
| Health Services Accessibility | 3 | 2021 | 10697 | 0.36 | Why? |
| Social Class | 1 | 2017 | 1360 | 0.36 | Why? |
| Epoetin Alfa | 2 | 2017 | 13 | 0.35 | Why? |
| Opiate Substitution Treatment | 1 | 2014 | 613 | 0.35 | Why? |
| Databases, Factual | 4 | 2018 | 6248 | 0.35 | Why? |
| Depressive Disorder | 1 | 2018 | 1236 | 0.34 | Why? |
| Residence Characteristics | 1 | 2018 | 1927 | 0.34 | Why? |
| Diabetes Mellitus | 3 | 2018 | 8207 | 0.34 | Why? |
| Particulate Matter | 6 | 2019 | 3249 | 0.34 | Why? |
| Population Surveillance | 3 | 2020 | 4967 | 0.33 | Why? |
| Educational Status | 1 | 2013 | 1451 | 0.32 | Why? |
| Air Pollutants | 6 | 2019 | 3110 | 0.32 | Why? |
| Quality Improvement | 2 | 2020 | 2435 | 0.32 | Why? |
| Pulmonary Disease, Chronic Obstructive | 3 | 2018 | 3832 | 0.31 | Why? |
| Multiple Sclerosis | 2 | 2021 | 2600 | 0.29 | Why? |
| Health Promotion | 2 | 2018 | 2020 | 0.29 | Why? |
| Mental Health | 2 | 2021 | 15770 | 0.27 | Why? |
| Health Resources | 1 | 2018 | 2592 | 0.27 | Why? |
| Decision Making | 4 | 2020 | 3132 | 0.26 | Why? |
| Hospitals | 3 | 2018 | 11793 | 0.25 | Why? |
| Primary Health Care | 2 | 2018 | 4839 | 0.24 | Why? |
| Opioid-Related Disorders | 1 | 2014 | 1185 | 0.23 | Why? |
| Myocardial Infarction | 4 | 2019 | 3361 | 0.23 | Why? |
| Emergency Service, Hospital | 4 | 2021 | 14232 | 0.22 | Why? |
| Socioeconomic Factors | 2 | 2019 | 8495 | 0.22 | Why? |
| Schools | 3 | 2021 | 4187 | 0.22 | Why? |
| Management Audit | 1 | 2020 | 39 | 0.22 | Why? |
| Formative Feedback | 1 | 2020 | 56 | 0.21 | Why? |
| Physical Abuse | 1 | 2021 | 78 | 0.21 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2017 | 3051 | 0.21 | Why? |
| Air Pollution | 5 | 2019 | 3504 | 0.21 | Why? |
| Child Behavior Disorders | 1 | 2021 | 107 | 0.20 | Why? |
| Power Plants | 1 | 2019 | 17 | 0.20 | Why? |
| Humans | 56 | 2021 | 930598 | 0.20 | Why? |
| Battered Women | 1 | 2019 | 23 | 0.20 | Why? |
| Patient Discharge | 3 | 2018 | 5696 | 0.19 | Why? |
| Drug Prescriptions | 2 | 2018 | 1062 | 0.19 | Why? |
| Trial of Labor | 1 | 2018 | 21 | 0.19 | Why? |
| Psychology, Child | 1 | 2021 | 206 | 0.19 | Why? |
| Psychology, Adolescent | 1 | 2021 | 208 | 0.18 | Why? |
| Randomized Controlled Trials as Topic | 4 | 2021 | 10649 | 0.18 | Why? |
| Epidemiologic Research Design | 1 | 2020 | 166 | 0.18 | Why? |
| Darbepoetin alfa | 1 | 2017 | 10 | 0.18 | Why? |
| Eating | 1 | 2021 | 395 | 0.18 | Why? |
| Medication Adherence | 2 | 2019 | 1270 | 0.17 | Why? |
| Cesarean Section | 2 | 2018 | 2089 | 0.17 | Why? |
| Reimbursement, Incentive | 1 | 2018 | 70 | 0.17 | Why? |
| Greenhouse Effect | 1 | 2017 | 48 | 0.17 | Why? |
| Clinical Audit | 1 | 2018 | 204 | 0.16 | Why? |
| Adolescent | 10 | 2021 | 86841 | 0.16 | Why? |
| Health Information Systems | 1 | 2018 | 130 | 0.16 | Why? |
| Ecology | 1 | 2018 | 140 | 0.16 | Why? |
| Erythropoiesis | 1 | 2017 | 71 | 0.16 | Why? |
| Crime Victims | 1 | 2019 | 148 | 0.16 | Why? |
| Comparative Effectiveness Research | 1 | 2017 | 178 | 0.16 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.16 | Why? |
| Percutaneous Coronary Intervention | 3 | 2018 | 3646 | 0.16 | Why? |
| Decision Making, Organizational | 1 | 2017 | 104 | 0.16 | Why? |
| Noise | 1 | 2019 | 194 | 0.16 | Why? |
| Muscle Spasticity | 1 | 2017 | 117 | 0.16 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.16 | Why? |
| Feedback | 1 | 2018 | 317 | 0.15 | Why? |
| Metals, Heavy | 1 | 2017 | 147 | 0.15 | Why? |
| Labor, Obstetric | 1 | 2018 | 257 | 0.15 | Why? |
| Peer Review | 1 | 2018 | 204 | 0.15 | Why? |
| Erythropoietin | 1 | 2017 | 167 | 0.15 | Why? |
| Cannabinoids | 1 | 2017 | 134 | 0.15 | Why? |
| Methadyl Acetate | 1 | 2014 | 2 | 0.15 | Why? |
| Quality Assurance, Health Care | 1 | 2020 | 596 | 0.15 | Why? |
| Cities | 4 | 2020 | 4937 | 0.15 | Why? |
| Inappropriate Prescribing | 1 | 2018 | 284 | 0.14 | Why? |
| Infectious Disease Medicine | 1 | 2017 | 311 | 0.14 | Why? |
| Meat | 1 | 2017 | 380 | 0.14 | Why? |
| Spatial Analysis | 1 | 2020 | 878 | 0.14 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.13 | Why? |
| Diagnostic Self Evaluation | 1 | 2018 | 394 | 0.13 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.13 | Why? |
| Cross-Over Studies | 1 | 2017 | 867 | 0.13 | Why? |
| Nausea | 1 | 2017 | 457 | 0.13 | Why? |
| Spatio-Temporal Analysis | 1 | 2020 | 1182 | 0.13 | Why? |
| Review Literature as Topic | 1 | 2017 | 387 | 0.13 | Why? |
| Epidemiologic Methods | 1 | 2018 | 392 | 0.13 | Why? |
| Parturition | 1 | 2018 | 514 | 0.13 | Why? |
| Environmental Exposure | 3 | 2019 | 1558 | 0.13 | Why? |
| Hospitals, High-Volume | 1 | 2017 | 688 | 0.13 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.13 | Why? |
| Quarantine | 4 | 2021 | 18418 | 0.13 | Why? |
| Treatment Outcome | 6 | 2021 | 51732 | 0.13 | Why? |
| Causality | 1 | 2017 | 857 | 0.13 | Why? |
| Rome | 3 | 2020 | 497 | 0.13 | Why? |
| Antidepressive Agents | 1 | 2018 | 509 | 0.13 | Why? |
| Violence | 1 | 2019 | 534 | 0.13 | Why? |
| Naloxone | 1 | 2014 | 153 | 0.12 | Why? |
| Adult | 17 | 2021 | 244371 | 0.12 | Why? |
| Insurance Coverage | 1 | 2017 | 348 | 0.12 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.12 | Why? |
| Polyethylene Glycols | 1 | 2017 | 574 | 0.12 | Why? |
| Female | 25 | 2021 | 380317 | 0.12 | Why? |
| Social Networking | 1 | 2019 | 737 | 0.12 | Why? |
| Vomiting | 1 | 2017 | 722 | 0.12 | Why? |
| Aged | 18 | 2021 | 215776 | 0.12 | Why? |
| Crowding | 1 | 2018 | 731 | 0.11 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.11 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.11 | Why? |
| Adrenal Cortex Hormones | 2 | 2021 | 6537 | 0.11 | Why? |
| Middle Aged | 21 | 2021 | 270681 | 0.11 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.11 | Why? |
| Methadone | 1 | 2014 | 296 | 0.11 | Why? |
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2017 | 529 | 0.11 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.11 | Why? |
| Bronchodilator Agents | 1 | 2016 | 444 | 0.11 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.11 | Why? |
| Male | 22 | 2021 | 367725 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Blood Transfusion | 2 | 2017 | 1399 | 0.11 | Why? |
| Algorithms | 3 | 2018 | 7346 | 0.11 | Why? |
| Hot Temperature | 1 | 2018 | 1299 | 0.10 | Why? |
| Hospital Departments | 1 | 2017 | 831 | 0.10 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.10 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.10 | Why? |
| Hip Fractures | 1 | 2018 | 667 | 0.10 | Why? |
| Research | 2 | 2020 | 2115 | 0.10 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.10 | Why? |
| Pyrazines | 1 | 2021 | 1783 | 0.10 | Why? |
| Policy Making | 1 | 2017 | 829 | 0.10 | Why? |
| Uncertainty | 1 | 2021 | 1888 | 0.10 | Why? |
| Cardiovascular Diseases | 4 | 2019 | 11497 | 0.10 | Why? |
| Amides | 1 | 2021 | 1864 | 0.10 | Why? |
| Child | 5 | 2021 | 70012 | 0.10 | Why? |
| Infant | 3 | 2021 | 30274 | 0.10 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2021 | 1322 | 0.10 | Why? |
| Pregnancy | 4 | 2020 | 23879 | 0.10 | Why? |
| Cause of Death | 2 | 2020 | 4823 | 0.09 | Why? |
| Marijuana Abuse | 1 | 2010 | 111 | 0.09 | Why? |
| Immunoglobulins, Intravenous | 1 | 2021 | 2705 | 0.09 | Why? |
| Buprenorphine | 1 | 2014 | 470 | 0.09 | Why? |
| Sleep | 1 | 2021 | 2695 | 0.09 | Why? |
| Suicide | 1 | 2021 | 1500 | 0.09 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.09 | Why? |
| Geography, Medical | 2 | 2020 | 537 | 0.09 | Why? |
| Health Policy | 2 | 2018 | 6242 | 0.08 | Why? |
| Motivation | 1 | 2018 | 1640 | 0.08 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.08 | Why? |
| Environmental Monitoring | 1 | 2019 | 3143 | 0.08 | Why? |
| Logistic Models | 2 | 2019 | 9089 | 0.08 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.08 | Why? |
| Plant Extracts | 1 | 2017 | 1514 | 0.08 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.08 | Why? |
| Neoplasms | 4 | 2020 | 17251 | 0.08 | Why? |
| Orthopedics | 1 | 2017 | 1279 | 0.07 | Why? |
| Risk Factors | 7 | 2018 | 71621 | 0.07 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2017 | 1692 | 0.07 | Why? |
| Diet | 1 | 2017 | 2052 | 0.07 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.07 | Why? |
| Substance-Related Disorders | 1 | 2019 | 2038 | 0.07 | Why? |
| Pregnant Women | 1 | 2018 | 2535 | 0.07 | Why? |
| Choice Behavior | 2 | 2018 | 319 | 0.07 | Why? |
| Practice Guidelines as Topic | 2 | 2019 | 15421 | 0.07 | Why? |
| Acute Coronary Syndrome | 1 | 2017 | 2107 | 0.06 | Why? |
| Mental Health Services | 1 | 2021 | 3007 | 0.06 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.06 | Why? |
| Emergency Medical Services | 1 | 2020 | 3557 | 0.06 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Delivery of Health Care | 3 | 2021 | 15909 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.06 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Surgeons | 1 | 2017 | 2233 | 0.06 | Why? |
| Information Dissemination | 1 | 2018 | 2986 | 0.06 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.06 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.06 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.06 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.06 | Why? |
| Pediatrics | 1 | 2017 | 2969 | 0.06 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.06 | Why? |
| Clinical Trials as Topic | 2 | 2018 | 7330 | 0.05 | Why? |
| Social Isolation | 1 | 2021 | 5932 | 0.05 | Why? |
| Therapeutic Equipoise | 1 | 2020 | 52 | 0.05 | Why? |
| Renal Dialysis | 1 | 2018 | 4358 | 0.05 | Why? |
| Exercise | 1 | 2021 | 6771 | 0.05 | Why? |
| Proportional Hazards Models | 3 | 2018 | 6543 | 0.05 | Why? |
| Models, Theoretical | 1 | 2019 | 6659 | 0.05 | Why? |
| Ambulatory Care | 1 | 2017 | 4947 | 0.05 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.05 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.05 | Why? |
| Models, Spatial Interaction | 1 | 2019 | 1 | 0.05 | Why? |
| Psychotic Disorders | 1 | 2010 | 924 | 0.05 | Why? |
| Communication | 1 | 2017 | 5206 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Plant Dispersal | 1 | 2018 | 1 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.05 | Why? |
| Teratogens | 1 | 2018 | 15 | 0.05 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.05 | Why? |
| Satellite Imagery | 1 | 2018 | 56 | 0.05 | Why? |
| Sicily | 1 | 2018 | 153 | 0.05 | Why? |
| Natural Resources | 1 | 2018 | 24 | 0.05 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.04 | Why? |
| Multilevel Analysis | 1 | 2017 | 104 | 0.04 | Why? |
| Epidemiology | 1 | 2020 | 216 | 0.04 | Why? |
| Fresh Water | 1 | 2018 | 59 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Stress, Psychological | 1 | 2021 | 10231 | 0.04 | Why? |
| Group Practice | 1 | 2016 | 13 | 0.04 | Why? |
| Sex Offenses | 1 | 2019 | 134 | 0.04 | Why? |
| Interrupted Time Series Analysis | 1 | 2021 | 868 | 0.04 | Why? |
| Urban Health | 1 | 2020 | 382 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.04 | Why? |
| Forests | 1 | 2018 | 132 | 0.04 | Why? |
| Societies, Scientific | 1 | 2020 | 414 | 0.04 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.04 | Why? |
| Motor Vehicles | 1 | 2019 | 223 | 0.04 | Why? |
| Hospital Mortality | 2 | 2018 | 22087 | 0.04 | Why? |
| Africa, Northern | 1 | 2018 | 539 | 0.04 | Why? |
| Dust | 1 | 2018 | 178 | 0.04 | Why? |
| Depression | 1 | 2021 | 14116 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Judgment | 1 | 2017 | 98 | 0.04 | Why? |
| Reproducibility of Results | 1 | 2013 | 11304 | 0.04 | Why? |
| Farms | 1 | 2018 | 269 | 0.04 | Why? |
| Meteorological Concepts | 1 | 2018 | 345 | 0.04 | Why? |
| Polypharmacy | 1 | 2019 | 347 | 0.04 | Why? |
| Seasons | 2 | 2019 | 4071 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Stroke | 1 | 2019 | 8839 | 0.04 | Why? |
| Social Perception | 1 | 2019 | 371 | 0.04 | Why? |
| Adrenergic beta-2 Receptor Agonists | 1 | 2017 | 142 | 0.04 | Why? |
| Emergencies | 2 | 2020 | 4095 | 0.04 | Why? |
| Anxiety | 1 | 2021 | 17311 | 0.04 | Why? |
| Vehicle Emissions | 1 | 2017 | 328 | 0.04 | Why? |
| Local Government | 1 | 2017 | 301 | 0.03 | Why? |
| Delayed-Action Preparations | 1 | 2016 | 291 | 0.03 | Why? |
| Physicians, Primary Care | 1 | 2017 | 298 | 0.03 | Why? |
| Critical Care | 1 | 2017 | 14081 | 0.03 | Why? |
| Secondary Prevention | 1 | 2019 | 762 | 0.03 | Why? |
| Geographic Information Systems | 1 | 2018 | 507 | 0.03 | Why? |
| European Union | 1 | 2017 | 565 | 0.03 | Why? |
| Diet, Mediterranean | 1 | 2017 | 351 | 0.03 | Why? |
| Decision Support Techniques | 1 | 2020 | 903 | 0.03 | Why? |
| Climate | 1 | 2018 | 557 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2019 | 9893 | 0.03 | Why? |
| Myocardial Ischemia | 1 | 2019 | 781 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Aerosols | 2 | 2019 | 5393 | 0.03 | Why? |
| Europe | 2 | 2019 | 12702 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2018 | 23402 | 0.03 | Why? |
| Health Care Reform | 1 | 2017 | 409 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2017 | 1647 | 0.03 | Why? |
| Cerebrovascular Disorders | 1 | 2019 | 1040 | 0.03 | Why? |
| Community Participation | 1 | 2017 | 605 | 0.03 | Why? |
| Ozone | 1 | 2018 | 757 | 0.03 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.03 | Why? |
| Housing | 1 | 2018 | 1146 | 0.02 | Why? |
| Waiting Lists | 1 | 2018 | 1388 | 0.02 | Why? |
| Advisory Committees | 1 | 2017 | 1418 | 0.02 | Why? |
| Pulmonary Medicine | 1 | 2016 | 706 | 0.02 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.02 | Why? |
| Vaccination Refusal | 1 | 2017 | 831 | 0.02 | Why? |
| Emigrants and Immigrants | 1 | 2017 | 888 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Professional Role | 1 | 2017 | 1280 | 0.02 | Why? |
| Registries | 2 | 2018 | 12327 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| General Practice | 1 | 2016 | 718 | 0.02 | Why? |
| Public Health | 3 | 2018 | 16359 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| Incidence | 2 | 2019 | 25622 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2019 | 7268 | 0.02 | Why? |
| Feeding Behavior | 1 | 2017 | 1909 | 0.02 | Why? |
| Public Policy | 1 | 2017 | 1894 | 0.02 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Parents | 1 | 2017 | 2758 | 0.02 | Why? |
| Meta-Analysis as Topic | 1 | 2010 | 1289 | 0.02 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.02 | Why? |
| Machine Learning | 1 | 2019 | 4395 | 0.01 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2016 | 17020 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.01 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.01 | Why? |